Krystal Biotech Receives European Commission Orphan Designation for KB407 for the Treatment of Cystic Fibrosis

18.01.2023 - PITTSBURGH, Jan. 18, 2023 (GLOBE NEWSWIRE) - Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a biotechnology company focused on developing and commercializing genetic medicines for patients with rare diseases, announced today that the ...

Related Keywords

Pennsylvania ,United States ,Suma Krishnan ,Krystal Biotech Inc ,European Medical Association ,European Commission ,Drug Administration ,Nasdaq ,Exchange Commission ,Committee For Orphan Medicinal Products ,European Union ,European Commission Orphan Designation ,Orphan Drug ,Orphan Medicinal ,Krystal Biotech ,Private Securities Litigation Reform Act ,